Tim Stenovec talks to husband and wife duo Talaat and Tai McNeely about when to bring up finances with your partner and what you need to be teaching your kids about money. The couple founded HisandHerMoney.com after Tai helped Talaat pay off $30,000 in debt!
Because of all his debt, Talaat kept his finances hidden from Tai under right before their wedding day...which he says was a terrible idea! He doesn't suggest talking about credit score on the first date, but slowly working it into a conversation before you even get engaged is very important. Tai says you want to attack finances as a team and help each other grow your bank account and credit.
Plus, once you're married and have kids the hard work doesn't stop. The McNeelys talk about teaching your kids how to give, spend and save. You can create a reward system for saving or even bring them to the bank and learn the process of depositing money.
Conditions have been mostly nice for travelers flying ahead of and on Christmas Day, but some naughty disruptions plagued those flying with Southwest Airlines again this year.
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
